Business Combinations and Asset Purchases (Fair Values of the Business Combinations and Allocations for the Acquisitions Completed) (Details) - USD ($)
|
12 Months Ended |
Dec. 29, 2019 |
Dec. 30, 2018 |
Dec. 31, 2017 |
Business Acquisition [Line Items] |
|
|
|
Goodwill |
$ 3,111,227,000
|
$ 2,952,608,000
|
$ 3,002,198,000
|
Fiscal Year 2019 Other Acquisitions [Member] |
|
|
|
Business Acquisition [Line Items] |
|
|
|
Business Acquisition, Cost of Acquired Entity, Cash Paid |
45,042,000
|
|
|
Business Acquisition, Cost of Acquired Entity, Liabilities Incurred, Contingent Consideration at Fair Value |
634,000
|
|
|
Working capital and other adjustments |
302,000
|
|
|
Less: cash acquired |
1,334,000
|
|
|
Business Combination, Consideration Transferred |
45,282,000
|
|
|
Current assets |
4,042,000
|
|
|
Property, plant and equipment |
727,000
|
|
|
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Noncurrent Assets |
481,000
|
|
|
Goodwill |
17,006,000
|
|
|
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities, Total |
(6,658,000)
|
|
|
Liabilities assumed |
(2,698,000)
|
|
|
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Long-term Debt |
(3,295,000)
|
|
|
Total |
45,282,000
|
|
|
Business Combination, Consideration Transferred, Liabilities Incurred |
638,000
|
|
|
Fiscal Year 2019 Other Acquisitions [Member] | United States of America, Dollars |
|
|
|
Business Acquisition [Line Items] |
|
|
|
Business Acquisition, Cost of Acquired Entity, Liabilities Incurred, Contingent Consideration at Fair Value |
12,700,000
|
|
|
Shandong Meizheng [Member] |
|
|
|
Business Acquisition [Line Items] |
|
|
|
Business Acquisition, Cost of Acquired Entity, Cash Paid |
145,000,000
|
|
|
Business Acquisition, Cost of Acquired Entity, Liabilities Incurred, Contingent Consideration at Fair Value |
12,100,000
|
|
|
Working capital and other adjustments |
2,961,000
|
|
|
Less: cash acquired |
2,108,000
|
|
|
Business Combination, Consideration Transferred |
164,399,000
|
|
|
Current assets |
15,160,000
|
|
|
Property, plant and equipment |
6,278,000
|
|
|
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Noncurrent Assets |
32,000
|
|
|
Goodwill |
81,457,000
|
|
|
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities, Total |
(21,231,000)
|
|
|
Liabilities assumed |
(706,000)
|
|
|
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Long-term Debt |
(10,991,000)
|
|
|
Total |
164,399,000
|
|
|
Business Combination, Consideration Transferred, Liabilities Incurred |
6,446,000
|
|
|
Cisbio Bioassays SAS [Member] |
|
|
|
Business Acquisition [Line Items] |
|
|
|
Business Acquisition, Cost of Acquired Entity, Cash Paid |
219,795,000
|
|
|
Business Acquisition, Cost of Acquired Entity, Liabilities Incurred, Contingent Consideration at Fair Value |
0
|
|
|
Working capital and other adjustments |
138,000
|
|
|
Less: cash acquired |
12,542,000
|
|
|
Business Combination, Consideration Transferred |
207,391,000
|
|
|
Current assets |
43,554,000
|
|
|
Property, plant and equipment |
4,835,000
|
|
|
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Noncurrent Assets |
100,000
|
|
|
Goodwill |
72,341,000
|
|
|
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities, Total |
(34,886,000)
|
|
|
Liabilities assumed |
0
|
|
|
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Long-term Debt |
(12,553,000)
|
|
|
Total |
207,391,000
|
|
|
Business Combination, Consideration Transferred, Liabilities Incurred |
0
|
|
|
Fiscal Year 2018 Acquisitions [Member] |
|
|
|
Business Acquisition [Line Items] |
|
|
|
Business Acquisition, Cost of Acquired Entity, Cash Paid |
|
95,950,000
|
|
Business Acquisition, Cost of Acquired Entity, Liabilities Incurred, Contingent Consideration at Fair Value |
|
6,200,000
|
|
Working capital and other adjustments |
261,000
|
|
|
Less: cash acquired |
|
1,132,000
|
|
Business Combination, Consideration Transferred |
|
104,633,000
|
|
Current assets |
4,905,000
|
|
|
Property, plant and equipment |
|
1,166,000
|
|
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Noncurrent Assets |
776,000
|
|
|
Goodwill |
65,886,000
|
|
|
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities, Total |
(9,049,000)
|
|
|
Liabilities assumed |
|
(461,000)
|
|
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Long-term Debt |
(3,881,000)
|
|
|
Total |
|
104,633,000
|
|
Business Combination, Consideration Transferred, Liabilities Incurred |
|
3,354,000
|
|
Fiscal Year 2017 Other Acquisitions [Member] |
|
|
|
Business Acquisition [Line Items] |
|
|
|
Business Acquisition, Cost of Acquired Entity, Cash Paid |
|
|
140,861,000
|
Working capital and other adjustments |
|
|
(93,000)
|
Less: cash acquired |
|
|
2,439,000
|
Business Combination, Consideration Transferred |
|
|
139,602,000
|
Current assets |
|
|
16,268,000
|
Property, plant and equipment |
|
|
11,356,000
|
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Noncurrent Assets |
|
|
1,691,000
|
Goodwill |
|
|
75,250,000
|
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities, Total |
|
|
(15,735,000)
|
Liabilities assumed |
|
|
0
|
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Long-term Debt |
|
|
(8,328,000)
|
Total |
|
|
139,602,000
|
Business Combination, Consideration Transferred, Liabilities Incurred |
|
|
1,273,000
|
EUROIMMUM [Member] |
|
|
|
Business Acquisition [Line Items] |
|
|
|
Business Acquisition, Cost of Acquired Entity, Cash Paid |
|
|
1,413,113,000
|
Working capital and other adjustments |
|
|
0
|
Less: cash acquired |
|
|
25,018,000
|
Business Combination, Consideration Transferred |
|
|
1,388,095,000
|
Current assets |
|
|
121,174,000
|
Property, plant and equipment |
|
|
109,859,000
|
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Noncurrent Assets |
|
|
71,621,000
|
Goodwill |
|
|
591,304,000
|
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities, Total |
|
|
(251,886,000)
|
Liabilities assumed |
|
|
(61,357,000)
|
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Long-term Debt |
|
|
(100,020,000)
|
Total |
|
|
1,388,095,000
|
Business Combination, Consideration Transferred, Liabilities Incurred |
|
|
0
|
Core Technology [Member] | Fiscal Year 2019 Other Acquisitions [Member] |
|
|
|
Business Acquisition [Line Items] |
|
|
|
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles |
27,667,000
|
|
|
Core Technology [Member] | Shandong Meizheng [Member] |
|
|
|
Business Acquisition [Line Items] |
|
|
|
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles |
36,500,000
|
|
|
Core Technology [Member] | Cisbio Bioassays SAS [Member] |
|
|
|
Business Acquisition [Line Items] |
|
|
|
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles |
90,000,000
|
|
|
Core Technology [Member] | Fiscal Year 2018 Acquisitions [Member] |
|
|
|
Business Acquisition [Line Items] |
|
|
|
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles |
31,956,000
|
|
|
Core Technology [Member] | Fiscal Year 2017 Other Acquisitions [Member] |
|
|
|
Business Acquisition [Line Items] |
|
|
|
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles |
|
|
12,400,000
|
Core Technology [Member] | EUROIMMUM [Member] |
|
|
|
Business Acquisition [Line Items] |
|
|
|
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles |
|
|
160,000,000
|
Trade Names [Member] | Fiscal Year 2019 Other Acquisitions [Member] |
|
|
|
Business Acquisition [Line Items] |
|
|
|
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles |
1,310,000
|
|
|
Trade Names [Member] | Shandong Meizheng [Member] |
|
|
|
Business Acquisition [Line Items] |
|
|
|
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles |
4,900,000
|
|
|
Trade Names [Member] | Cisbio Bioassays SAS [Member] |
|
|
|
Business Acquisition [Line Items] |
|
|
|
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles |
5,000,000
|
|
|
Trade Names [Member] | Fiscal Year 2018 Acquisitions [Member] |
|
|
|
Business Acquisition [Line Items] |
|
|
|
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles |
|
1,070,000
|
|
Trade Names [Member] | Fiscal Year 2017 Other Acquisitions [Member] |
|
|
|
Business Acquisition [Line Items] |
|
|
|
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles |
|
|
3,000,000
|
Trade Names [Member] | EUROIMMUM [Member] |
|
|
|
Business Acquisition [Line Items] |
|
|
|
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles |
|
|
36,000,000
|
Customer Relationships [Member] | Fiscal Year 2019 Other Acquisitions [Member] |
|
|
|
Business Acquisition [Line Items] |
|
|
|
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles |
6,700,000
|
|
|
Customer Relationships [Member] | Shandong Meizheng [Member] |
|
|
|
Business Acquisition [Line Items] |
|
|
|
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles |
53,000,000
|
|
|
Customer Relationships [Member] | Cisbio Bioassays SAS [Member] |
|
|
|
Business Acquisition [Line Items] |
|
|
|
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles |
39,000,000
|
|
|
Customer Relationships [Member] | Fiscal Year 2018 Acquisitions [Member] |
|
|
|
Business Acquisition [Line Items] |
|
|
|
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles |
10,200,000
|
|
|
Customer Relationships [Member] | Fiscal Year 2017 Other Acquisitions [Member] |
|
|
|
Business Acquisition [Line Items] |
|
|
|
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles |
|
|
43,700,000
|
Customer Relationships [Member] | EUROIMMUM [Member] |
|
|
|
Business Acquisition [Line Items] |
|
|
|
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles |
|
|
710,000,000
|
In Process Research and Development [Member] | Fiscal Year 2017 Other Acquisitions [Member] |
|
|
|
Business Acquisition [Line Items] |
|
|
|
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles |
|
|
0
|
In Process Research and Development [Member] | EUROIMMUM [Member] |
|
|
|
Business Acquisition [Line Items] |
|
|
|
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles |
|
|
1,400,000
|
GC Libraries [Member] | Fiscal Year 2018 Acquisitions [Member] |
|
|
|
Business Acquisition [Line Items] |
|
|
|
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles |
2,065,000
|
|
|
Diagnostics [Member] |
|
|
|
Business Acquisition [Line Items] |
|
|
|
Goodwill |
1,612,407,000
|
1,617,616,000
|
1,657,963,000
|
Discovery & Analytical Solutions [Member] |
|
|
|
Business Acquisition [Line Items] |
|
|
|
Goodwill |
$ 1,498,820,000
|
$ 1,334,992,000
|
$ 1,344,235,000
|